Key facts
- It has raised $122.3M; the latest was Later Stage VC ($15.0M) in Jul 2024.
- Notable investors include Balderton Capital, Daphni, Accomplice VC, L Catterton, Common Metal — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for ZOE
- ·The full record, as it builds
Funding rounds
No funding rounds for ZOE are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ZOE
Provider of medical testing services intended to deliver recommendations on personalized dietary plans for individuals. The company's services involve testing for the gut, blood fat, and blood sugar responses of patients with at-home test kits and delivering personalized insights that are used to develop a four-week dietary plan, while the in-house mobile application offers food scores and recommendations on making smart dietary swaps, week by week, enabling users to improve their gut health and live better.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2017
- Employees
- 483
- Website
- zoe.com/
- Ownership
- Privately Held (backing)
ZOE doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ZOE shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ZOE in its N-PORT filings yet. We sweep new filings monthly.